Physician
Cardiology
Dr. Daniel F. Pauly, MD
|
|
Give Review
Dr. Daniel F. Pauly practices Cardiology. He went to medical school at University of Alabama School of Medicine. University of Alabama School of Medicine is ranked 37 in research and 17 in primary care medicine He received awards:"CMS Meaningful Use Stage 1 Certification", "Fellow (FACP)" and "Fellow (FACC)". Daniel F. Pauly, MD is a published doctor and has 71 publications published. The lastest was: 'Complete correction of acid alpha-glucosidase deficiency in Pompe disease fibroblasts in vitro, and lysosomally targeted expression in neonatal rat cardiac and skeleta...' Daniel Pauly is registered with Medicare and accepts Medicare payments.
Publications
- Managing Acute decompensated heart failure.
- Cardiac Allograft Vasculopathy by Intravascular Ultrasound in Heart Transplant Patients: Substudy From the Everolimus Versus Mycophenolate Mofetil Randomized, Multicen...
- Prognostic significance of biomarkers in predicting outcome in patients with Coronary artery disease and left ventricular dysfunction: results of the biomarker substud...
- Effect of Cytochrome P450 3A5 Genotype on Atorvastatin Pharmacokinetics and Its Interaction with Clarithromycin.
- In women with symptoms of cardiac ischemia, nonobstructive Coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated wit...
- The slow cardiac myosin regulatory light chain in Heart failure.
- Renin-angiotensin gene polymorphisms and neurohormonal inhibition.
- Multimarker approach predicts adverse cardiovascular events in women evaluated for suspected ischemia: results from the National Heart, Lung, and Blood Institute-spons...
- Tricuspid annular motion as a predictor of severe right ventricular Failure after left ventricular assist device implantation.
- Design of a phase 1/2 trial of intracoronary administration of AAV1/SERCA2a in patients with Heart failure.
- Incidence, predictors, and outcomes of cardiac pacing after cardiac transplantation: an 11-year retrospective analysis.
- Cardiorenal interactions: insights from the ESCAPE trial.
- Characterization and prognostic value of persistent hyponatremia in patients with severe Heart failure in the ESCAPE Trial.
- Arterial-wave reflections are increased in Heart failure patients with a left-ventricular assist device.
- Initial Heart rate and systolic blood pressure predict outcomes in chronic Heart failure patients who are evaluated for cardiac transplant.
- Synergistic polymorphisms of beta1 and alpha2C-adrenergic receptors and the influence on left ventricular ejection fraction response to beta-blocker therapy in Heart f...
- Cardiac transplantation in patients with anti-phospholipid antibodies.
- Magnetic resonance imaging of primary cardiac lymphoma.
- Relation of beta(2)-adrenoceptor haplotype to risk of death and Heart transplantation in patients with Heart failure.
- Estrogen and different aspects of vascular Disease in women and men.
- Discordant beta-blocker effects on clinic, ambulatory, resting, and exercise hemodynamics in patients with Hypertension.
- Sustained restoration of autonomic balance with long- but not short-acting metoprolol in patients with Heart failure.
- Atrial fibrillation as a cause of left ventricular dysfunction after cardiac transplantation.
- Managing the post-left ventricular assist device patient.
- Management of Heart failure after cardiac resynchronization therapy: integrating advanced Heart failure treatment with optimal device function.
- Cardiac function and Heart failure.
- Beta1-adrenergic receptor polymorphisms and left ventricular remodeling changes in response to beta-blocker therapy.
- beta-Adrenergic receptor polymorphisms and responses during titration of metoprolol controlled release/extended release in Heart failure.
- Early outcomes of a care coordination-enhanced telehome care program for elderly veterans with chronic Heart failure.
- Pharmacokinetics and CYP2D6 genotypes do not predict metoprolol adverse events or efficacy in Hypertension.
- Ischemic Heart disease: metabolic approaches to management.
- Dobutamine-related asthma in a patient awaiting cardiac transplantation: the eosinophilic dilemma.
- Vascular effects of sildenafil in Hypertensive cardiac transplant recipients.
- Genetic variation in lectin-like oxidized low-density lipoprotein receptor 1 (LOX1) gene and the risk of Coronary artery disease.
- Beta 1-adrenergic receptor polymorphisms and antiHypertensive response to metoprolol.
- Sustained use of nesiritide to aid in bridging to Heart transplant.
- The role of carnitine in Myocardial dysfunction.
- Comparison of dobutamine versus milrinone therapy in hospitalized patients awaiting cardiac transplantation: a prospective, randomized trial.
- QRS duration variability in patients with Heart failure.
- Percutaneous Coronary intervention versus medical therapy for Coronary allograft vasculopathy. One center's experience.
- Correction of the enzymatic and functional deficits in a model of Pompe Disease using adeno-associated virus vectors.
- Anti-CD20 monoclonal antibody (rituximab) therapy for Acute cardiac humoral rejection: a case report.
- Intercellular transfer of the virally derived precursor form of acid alpha-glucosidase corrects the enzyme deficiency in inherited cardioskeletal myopathy Pompe Disease.
- D-Ribose as a supplement for cardiac energy metabolism.
- Reduced left ventricular dimension and normalized atrial natriuretic hormone level after repair of Aortic coarctation in an adult.
- Complete correction of acid alpha-glucosidase deficiency in Pompe Disease fibroblasts in vitro, and lysosomally targeted expression in neonatal rat cardiac and skeleta...
- Protection by verapamil of mitochondrial glutathione equilibrium and phospholipid changes during reperfusion of ischemic canine myocardium.
- Mitochondrial inclusions and mitochondrial respiratory function in selenite-treated mammary epithelial cell lines.
- Importance of acyl-CoA availability in interpretation of carnitine palmitoyltransferase I kinetics.
- Carnitine-acylcarnitine translocase in ischemia: evidence for sulfhydryl modification.
- Control of mitochondrial respiration in muscle.
- Chymotrypsin activates cardiac mitochondrial carnitine-acylcarnitine translocase.
- Selenium distribution in mammary epithelial cells reveals its possible mechanism of inhibition of cell growth.
- Mitochondrial adenosine triphosphatase in the oxyphil cells of a renal oncocytoma.
- Carnitine palmitoyltransferase in cardiac ischemia. A potential site for altered fatty acid metabolism.
- Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling.
- Influence of phenotype and pharmacokinetics on beta-blocker drug target pharmacogenetics.
- The benefits of ribose in cardiovascular Disease.
- Legionella bacteria in aerosols: sampling and analytical approaches used during the legionnaires Disease outbreak in Pas-de-Calais.
- Association between the severity of angiographic coronary artery disease and paraoxonase gene polymorphisms in the National Heart, Lung, and Blood Institute-sponsored ...
- APOE polymorphism and angiographic Coronary artery disease severity in the Women''s Ischemia Syndrome Evaluation (WISE) study.
- Coronary microvascular reactivity is only partially predicted by atherosclerosis risk factors or Coronary artery disease in women evaluated for suspected ischemia: res...
- Clinical implications and longitudinal alteration of peripheral blood transcriptional signals indicative of future cardiac allograft rejection.
- Transcriptional signals of T-cell and corticosteroid-sensitive genes are associated with future Acute cellular rejection in cardiac allografts.
- Simplified method for determination of clarithromycin in human plasma using protein precipitation in a 96-well format and liquid chromatography-tandem mass spectrometry.
- Constrictive pericarditis presenting as a calcified anterior cardiac mass.
- Calcium upregulation by percutaneous administration of gene therapy in cardiac Disease (CUPID Trial), a first-in-human phase 1/2 clinical trial.
- Association of anti-oxidized LDL and candidate genes with severity of Coronary stenosis in the Women''s Ischemia Syndrome Evaluation study.
- Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intraCoronary gene therapy of sarcoplasmic reticulum...
- Myocardial recovery in peripartum Cardiomyopathy: prospective comparison with recent onset Cardiomyopathy in men and nonperipartum women.
Schools
University of Alabama At Birmingham
Johns Hopkins University Hospital
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Automatic Implantable Cardioverter Defibrillator (ICD) Implantation
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- View All
Conditions Treated
- Acute Venous Embolism Thrombosis
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACP)
- Fellow (FACC)
Education
-
Johns Hopkins University -
University of Alabama School of Medicine
Hospital
-
UF Health Shands Hospital
Drug Facts
| NPI NUMBER | 1003823329 | |
| NPPES Provider LastName | PAULY | |
| NPPES Provider FirstName | DANIEL | |
| NPPES Provider ZIPCode | 641082640 | |
| NPPES Provider State | MO | |
| Specialty Description | Cardiology | |
| Total Claim Count | 460.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1003823329 |
| Last Name Of The Provider | PAULY |
| First Name Of The Provider | DANIEL |
| View All |
Similar Doctors
|
|
Suzanne Titus, NP
 This Doctor is OpenDoctor Recommended.
|
|
Dr. H William Stites III, MD |
|
Dr. Alec D. Weisberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jin S. Park, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Annette M. Quick, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paramdeep S. Baweja, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ashutosh V. Bapat, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Suzanne J. Baron, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Abhinav Sharma, MD |